Specifically, Heng Ren demands that Sinovac's Board of Directors announce a distribution of $8.9 billion in cash to its shareholders and cause the resumption of trading of the Company's shares.
Like you, we are shareholders in Sinovac Biotech Ltd. ("Sinovac" or the "Company"). Heng Ren Partners, LLC ("Heng Ren") manages funds that have held Sinovac shares since 2018. Heng Ren has long ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback